ONYX-015 is an adenovirus that lacks the E1B-55K gene product for p53 degradation. Thus, ONYX-015 was conceived as an oncolytic virus that would selectively replicate in p53-defective tumor cells. Here we show that loss of E1B-55K leads to the induction, but not the activation, of p53 in ONYX-015-infected primary cells. We use a novel adenovirus mutant, ONYX-053, to demonstrate that loss of E1B-55K-mediated late viral RNA export, rather than p53 degradation, restricts ONYX-015 replication in primary cells. In contrast, we show that tumor cells that support ONYX-015 replication provide the RNA export function of E1B-55K. These data reveal that tumor cells have altered mechanisms for RNA export and resolve the controversial role of p53 in governing ONYX-015 oncolytic selectivity.
Introduction
tially tumorigenic lesions (Levine, 1997; Oren, 2003) . Thus, inactivation of the p53 tumor suppressor pathway is a critical event There is a great need to identify therapies that trigger the rapid for tumorigenesis. and specific death of tumor cells. Lytic viruses, whose replicap53 was first identified through its interaction with a DNA tion is tumor-selective, offer a novel and specific approach to viral protein, SV40 large T antigen (Lane and Crawford, 1979 ; cancer therapy, with the potential to be self-perpetuating, kill Linzer and Levine, 1979) . Like tumor cells, DNA viruses inactitumors through regulated lytic death and spread not only within vate the p53 pathway, and many encode proteins that bind and the tumor but also to distant micrometastases. dl1520/ONYXdegrade p53. Viral replication induces p53 due to expression 015 is the prototype for oncolytic adenoviral therapy (Khuri et of potent viral oncogenes, such as adenovirus E1A (Chiou and al., 2000) . It was originally conceived as an oncolytic virus that White, 1997; Lowe and Ruley, 1993) , and/or the propagation of would selectively replicate in tumor cells in which the p53 tumor double-stranded DNA viral genomes (Raj et al., 2001 ). Thus, suppressor pathway is dysfunctional (Bischoff et al., 1996) . viral proteins that inactivate p53 are thought to play a requisite The p53 tumor suppressor pathway is inactivated in nearly role in viral replication by preventing p53-mediated cell cycle all human tumors, either through direct mutation of p53 or the arrest or apoptosis. In adenovirus infection, E1B-55K appears to fulfill this role, as together with E4-ORF6 and cellular proteins loss of upstream regulators such as p14 ARF or downstream p53 effectors such as Bax (Sherr and McCormick, 2002) . DNA daminvolved in ubiquitination, it induces the degradation of p53 (Harada et al., 2002; Querido et al., 1997 Querido et al., , 2001 ). ONYX-015 age or activated oncogenes induce p53. which activates the transcription of downstream p53 effectors, resulting in the cell (dl1520) is an adenovirus mutant that lacks the E1B-55K gene and, therefore, fails to degrade p53 during viral replication cycle arrest or apoptosis of cells that may have acquired poten- Quiescent primary small airway epithelium cells (SAECs) were infected at a multiplicity of infection (moi) of 10 with ⌬E1A (dl312) control, WtD, or ONYX-015 adenovirus. A: At various hours postinfection (h.p.i.), lysates were generated and examined for p53, various early and late adenoviral proteins as indicated (h ϭ hexon, p ϭ penton, f ϭ fiber), and ␤-actin (loading control) expression by Western blotting. B: Infected cells were fixed at 24 h.p.i. and analyzed for p53 and E1B-55K expression patterns by immunofluorescence. (Barker and Berk, 1987; Bischoff et al., 1996) . On this basis, it RNA in the absence of E1B-55K, a propensity not shared by primary cells. Thus, loss of E1B-55K-mediated late viral RNA was predicted that ONYX-015 would be restricted for replication in normal cells, but would be capable of replicating in p53-export rather than p53 degradation is the major determinant of ONYX-015 tumor-selective replication. These results provide deficient tumor cells. ONYX-015 has undergone extensive clinical testing, with proven safety and evidence of promising clinical important new insights into the regulation of RNA export in tumor versus normal cells and also suggest that adenovirus has activity from several indications (Khuri et al., 2000; Kirn, 2001; Reid et al., 2002; Ries and Korn, 2002; Rudin et al., 2003) .
evolved a novel strategy for inactivating p53 in the absence of E1B-55K. Moreover, biopsies from patients injected with ONYX-015 revealed that the production of ONYX-015 viral particles is restricted to tumor tissue and not observed in normal tissue that Results had been injected adjacent to the tumor mass (Khuri et al., 2000) .
ONYX-015 replication is defective in primary cells Nevertheless, the precise role of p53 in determining ONYXand induces high levels of nuclear p53 015 selectivity remains highly controversial (Goodrum and Or- To determine whether ONYX-015 replication is defective in prinelles, 1998; Hall et al., 1998; Hann and Balmain, 2003 Rothmann et al., 1998; Turnell et al., 1999) . This is passage human primary epithelial cells. ONYX-015 production partly because ONYX-015 can replicate in several tumor cell was attenuated compared to wild-type virus in primary cells. A lines that retain wild-type p53 sequences. However, this could nonreplicating control virus, ⌬E1A (Table 1) , is a measure of be attributed to the indirect inactivation of the p53 pathway in input in this assay. We next examined the kinetics of early and tumor cells due to the loss of upstream regulators, such as late viral protein expression in ONYX-015-and wild-type virusp14 ARF (Ries et al., 2000) . More confounding has been the reinfected SAECs, as shown in Figure 1A . The onset of early viral quirement for an E1B-55K late function for replication of ONYXprotein expression (E1B-19k, E2A, E4-ORF3, E4-ORF6, E4-ORF 015 in some tumor cell lines but not in others, irrespective of 6/7) in ONYX-015-infected SAECs closely paralleled that of wildtheir p53 status (Harada and Berk, 1999) . Furthermore, it has type virus. In contrast, the onset and level of late protein expression (hexon, penton, fiber) was impaired in ONYX-015-infected been proposed that p53 may even be required for productive
SAECs. There is a distinct lack of late protein expression in adenoviral replication (Hall et al., 1998) .
ONYX-015-infected SAECs compared to WtD at 24 hours postThus, the poorly understood late functions of E1B-55K in infection (h.p.i.), and ultimately a 3-to 5-fold reduction (as quanviral replication, together with the difficulties of assessing p53 titated on a phosphorimager) in the levels of late proteins at function in tumor cells, have made the mechanism underlying 48 h.p.i., with hexon being the most severely affected. The ONYX-015 oncolytic selectivity difficult to determine. Here we attenuation of ONYX-015 replication and late protein expression resolve the role of p53 in determining ONYX-015 selectivity in in normal cells correlated with the loss of E1B-55K-mediated primary epithelial cells where all components of the p53 pathway p53 degradation, resulting in high levels of nuclear p53 (Figures are intact. In addition, we use a novel adenovirus mutant, ONYX-1A and 1B). 053, to distinguish between the p53-dependent and -independent functions of E1B-55K. We demonstrate that loss of E1B-55K leads to the induction, but not the activation, of p53 in Accelerated S phase entry in normal cells infected with ONYX-015 ONYX-015-infected primary cells. Consequently, the replication of ONYX-015 in primary cells is not restricted by p53. ONYX-015
One of the best-known effects of p53 induction is cell cycle arrest. In adenovirus infection, the E1A viral protein activates tumor-selective replication appears to be instead determined by a unique property of tumor cells to efficiently export late viral E2F and drives S phase entry. To determine whether p53 blocks this process in ONYX-015-infected normal cells, we examined were reached using an Acridine Orange/Ethidium Bromide assay for apoptosis (data not shown). Consistent with this, in S phase entry at various times postinfection (Figures 2A and 2B) . Unexpectedly, SAECs infected with ONYX-015 entered S ONYX-015 infection, p53 did not potentiate Caspase 3-mediated apoptosis, as evidenced by similar levels of Caspase-3 phase more efficiently than cells infected with wild-type adenovirus. This correlated with sustained higher levels of E1A in and PARP cleavage in ONYX-015 and wild-type virus infected cells ( Figure 3B ). Furthermore, ZVAD, which inhibits caspase ONYX-015-infected cells ( Figure 2C ), and over a 10-fold increase in viral genomes at 48 h.p.i. (Figure 2D ) compared to activation, did not rescue ONYX-015 replication ( Figure 3C ), although in the same cells it was sufficient to prevent TNF/ wild-type virus-infected cells. We believe these effects are due to the failure of ONYX-015 to shut down translation of early viral cycloheximide-mediated cell death (data not shown). Thus, p53-mediated apoptosis does not account for the dramatic attenuamRNAs, such as E1A, together with cellular RNAs, as shown in Figure 5B . Nevertheless, it is of considerable interest that tion of ONYX-015 replication in normal cells. Based on this evidence, we conclude that p53 does not attenuate ONYX-015 ONYX-015 provokes entry into S phase despite the induction of high levels of nuclear p53 in infected cells.
replication by preventing S phase entry or significantly increasing apoptosis. p53 does not induce caspase-mediated apoptosis in ONYX-015-infected primary cells p53 is induced, but not activated, in ONYX-015-infected cells p53 induction can also promote apoptosis. Therefore, we determined whether premature p53-dependent apoptosis accounted
In ONYX-015-infected primary cells, supraphysiologically high levels of p53 fail to provoke the expected biological effects, for the attenuation of ONYX-015 replication in normal cells. However, despite extremely high levels of E1A and p53, there suggesting that p53 activity is blocked downstream. p53 is thought to function primarily by inducing the transcription of was never more than a minor increase in apoptosis (at most an 8% increase in Annexin V/PI positive cells) in ONYX-015 versus downstream effectors (Chao et al., 2000; Jimenez et al., 2000; Oren, 2003) . Therefore, we examined two well-characterized wild-type virus infected cells ( Figure 3A ). Similar conclusions Quiescent SAECs were infected with ⌬E1A, WtD, or ONYX-015 at moi 10 and cell cycle parameters examined at various h.p.i. A: Cell cycle analysis was performed by quantifying propidium iodide incorporation using a FACS Calibur. The time point shown is at 24 h.p.i. and is from a representative experiment. B: The % change in S phase relative to t ϭ 0 is plotted at various times postinfection. C: Cell lysates were generated and examined for expression of p53, Cyclin A, Cyclin B, and ␤-actin as well as Cdc2 Y15 phosphorylation by Western blot analysis. D: DNA was isolated and viral genomes quantified by real-time Q-PCR as described in the methods.
p53 downstream targets, p21 and Mdm2, in infected SAECs.
together with an E1B-55K deletion ( Figure 4C , right panel). ONYX-101 is an adenovirus mutant which encodes only the Surprisingly, despite the induction of both p14 ARF and high levels of p53, neither p21 nor Mdm2 protein expression was induced E1A-p300 binding mutation. Like ONYX-015, ONYX-605 also failed to activate p53-mediated transcription significantly. This during ONYX-015 infection over that of control ⌬E1A-infected cells ( Figure 4A ). In contrast, exposure of SAECs to ionizing suggests that the binding pf p300 to the amino terminus of E1A does not account for the suppression of p53-directed transcripradiation induced both p53 and p21 in a dose-dependent manner, confirming that these uninfected primary cells are fully comtion in ONYX-015-infected primary cells. petent for p53 function ( Figure 4B ). In addition to p21 and Mdm2, One notable exception was Bax, a p53 target gene whose p53 induces the transcription of several other downstream tarmRNA levels increased significantly following ONYX-015 infecgets and effectors, including 14-3-3 , Cyclin G, GADD45, PIG-3, tion ( Figure 4D ). However, in ONYX-015-infected H1299 cells, PERP, and Bax (Attardi et al., 2000; Oren, 2003; Yu et al., 1999) .
which are deficient for p53, Bax mRNA was induced to similar We used real-time Q-PCR to directly determine whether the tranlevels and, thus, occurs due to loss of a p53-independent funcscription of any of these p53 targets was induced in ONYX-015-tion of E1B-55K ( Figure 4D , right panel). It is tempting to specuinfected SAECs. Irradiated SAECs exhibited only a moderate late that Bax induction may account for the small increase in induction of p53 protein levels compared to ONYX-015-infected apoptosis observed in ONYX-015-infected cells. However, we SAECs. Nevertheless, we observed an appreciable induction of did not detect corresponding increases in Bax protein by Westendogenous p53 transcriptional target genes in irradiated ern blotting (data not shown). We conclude that in ONYX-015-SAECs ( Figure 4C ). Likewise, infection with a nonreplicating infected primary cells, nuclear p53 accumulates to supraphysiocontrol virus also induced p53 transcriptional targets, presumlogically high levels, but does not induce the transcription of ably through a DNA damage/stress response, triggered either downstream effectors and is thus unlikely to restrict ONYX-015 by viral DNA or the infection process itself. In contrast, despite replication. the presence of extremely high levels of p53 in ONYX-015-infected primary SAECs, downstream p53 transcriptional tar-ONYX-053 infection distinguishes between the p53-dependent and -independent functions of E1B-55K for viral replication gets were not induced. Similar results were also obtained in ONYX-015-infected mammary epithelial cells (data not shown).
in primary cells These data suggest that the restriction of ONYX-015 replication Furthermore, many p53 transcriptional targets decreased upon ONYX-015 infection, analogous to wild-type virus infection in in normal cells is likely to be due to p53-independent functions of E1B-55K, or, alternatively, novel functions of p53. The bestwhich p53 is degraded.
These data suggest that p53-mediated transcription can be characterized p53-independent function of E1B-55K is in mediating the shutdown of host protein synthesis, which is thought inactivated independently of E1B-55K in an adenovirus infection. E1A binds and inactivates p300 (Chiou and White, 1997;  to facilitate late viral protein production. To distinguish between these possibilities, we analyzed the replication of a unique ade- Thomas and White, 1998) , an important coactivator for p53-mediated transcription and histone acetylation (Espinosa and novirus mutant, ONYX-053, in primary cells. This mutant expresses a point mutant of E1B-55K (H260A) that fails to bind Emerson, 2001 ). Therefore, we examined an adenovirus mutant, ONYX-605, which comprises an E1A-p300 binding mutation and degrade p53, yet retains all measurable late functions of As noted above, the best characterized functions of E1B-55K, aside from p53 binding, relate to the shutoff of host protein synthesis and the export of late viral RNAs (Babiss et al., 1985; Leppard and Shenk, 1989; Pilder et al., 1986) , which are thought to be necessary for a productive viral infection. Therefore, we determined the ability of ONYX-015 and ONYX-053 to shut off host protein synthesis in primary cells. We measured host protein shutoff by determining S 35 methionine incorporation into cellular and viral proteins in infected cells ( Figure 5B ). Host protein shutoff was observed at 36 h.p.i. in wild-type virusinfected cells, consistent with its onset occurring post-DNA replication. As expected, ONYX-015 failed to shut off the translation of host RNAs, whereas ONYX-053 mediated host protein shutoff almost as efficiently as wild-type virus.
Defective late viral RNA export, not p53 induction, restricts ONYX-015 replication in primary cells E1B-55K is thought to mediate the switch from host to viral protein synthesis by promoting the preferential export and translation of late viral RNAs, such as fiber and hexon. Consistent with this, we had observed over a 3-to 5-fold defect in the levels of fiber and hexon protein expression in ONYX-015-infected SAECs compared to WtD ( Figure 1A ). To determine whether this correlated with a defect in late viral RNA export in the absence of E1B-55K, we examined the cytoplasmic/nuclear ratios of spliced fiber RNA by real-time Q-PCR in ONYX-15-and WtD-infected SAECs ( Figure 6A ). There was a 3-to 4-fold defect in the cytoplasmic/nuclear ratio of fiber RNA in ONYX-015-infected SAECs compared to WtD, consistent with the defect observed in late viral protein expression.
Nevertheless, real-time Q-PCR quantitates the levels of the gene of interest relative to an endogenous gene, in this case www.cancercell.org/cgi/content/full/6/6/611/DC1/). RNA FISH confirmed our real-time Q-PCR analysis and demonstrated that the export of fiber ( Figure 6A ) and hexon ( Figure 6B ) RNA is defective in ONYX-015-infected SAECs compared to both E1B-55K for viral replication (Shen et al., 2001) . Two other E1B-ONYX-053 and wild-type virus. Clearly, late viral RNAs do enter 55K viral mutants, ONYX-051 and ONYX-052, were also dethe cytoplasm in ONYX-015-infected cells, as evidenced by scribed as having such properties in tumor cell lines (Shen et cytoplasmic staining in a percentage of ONYX-015-infected al., 2001). However, in primary cells, these viruses induced p53 cells ( Figures 6A and 6B , top panel), and late viral protein expresdegradation (data not shown), suggesting that the ability of sion in Figure 1A , albeit delayed and at lower levels. Based these E1B-55K point mutants to bind p53 may be affected by on this evidence, we conclude that there is a defect in the tumor-specific modifications. Figure 5A shows that primary cells accumulation of late viral RNAs in the cytoplasm of ONYX-015-infected with ONYX-053, like ONYX-015, accumulate high levels of p53. Similar to ONYX-015, high levels of p53 in ONYX-053-infected primary cells. These data also allow us to visualize by immunofluorescence infected cells also failed to induce downstream p53 transcriptional targets ( Figure 4C) , again with the exception of Bax (Figure the direct role of E1B-55K in the transport of late viral RNAs. In cells infected with wild-type adenovirus, E1B-55K (red) was 4D). Thus, both ONYX-015-and ONYX-053-infected SAECs accumulate high levels of p53 due to loss of E1B-55K-mediated nuclear, but localized to the cytoplasm coincident with hexon and fiber RNAs ( Figures 6A and 6B , lower panels). Consistent p53 degradation. 
not induced
A: Quiescent SAECs were infected with ⌬E1A, WtD, or ONYX-015 at moi 10 and examined at various h.p.i. for p53, p14 ARF , p21, Mdm2, and ␤-actin expression by Western blot analysis. B: SAECs were analyzed at various time points following treatment with increasing doses of ␥ radiation for p53, p21, and ␤-actin expression by Western blotting. C: The induction of p53 transcriptional targets in SAECs that had either been irradiated with 8 Gy of ␥ radiation or infected with ⌬E1A, WtD, ONYX-015, ONYX-053, ONYX-101, or ONYX-605 adenovirus was determined at various time points by realtime Q-PCR. The fold induction of mRNAs relative to t ϭ 0 is shown. cDNAs were normalized relative to either 18S or GUS expression with similar conclusions; GUS data is plotted. p53 protein levels were determined in the same experiment by Western blot analysis. D: The induction of Bax mRNA in infected SAECs and H1299 tumor cells (moi 10) was determined at various h.p.i. by real-time Q-PCR. The fold induction relative to t ϭ 0 at 24 (gray and white bars) and 36 (black bar) h.p.i. in each cell type is plotted.
with the failure of ONYX-053 to degrade p53 during infection, with the loss of p53 degradation and cytoplasmic localization of E1B-55K. While ONYX-053 is not completely wild-type for E1B-55K was localized predominantly in the cytoplasm and also did not colocalize with hexon RNA in the nucleus (Figures 6A host protein shutoff, our data suggest that neither nuclear retention nor robust E4-ORF6 binding is absolutely required for transand 6B, middle panel). A striking transition of fiber RNA from a diffuse nuclear pattern to the nuclear edge was also observed port of late viral RNAs by E1B-55K, and that E4-ORF6 may act independently of E1B-55K to regulate late viral protein expreson export of viral RNAs ( Figure 6A ). E1B-55K is a shuttle protein that is retained in the nucleus by E4-ORF6 (Goodrum et al., sion. Alternatively, E1B-55K and E4-ORF6 may still depend on each other to mediate different aspects of late viral RNA export, 1996; Kratzer et al., 2000; Orlando and Ornelles, 2002) , and with which it forms a complex to degrade p53 (Harada et al., although their colocalization may not be required.
To determine whether p53 accumulation or defects in host 2002; Querido et al., 1997 Querido et al., , 2001 ). Thus, adenoviral mutants lacking E4-ORF6 also fail to degrade p53. An E1B-55K/E4-protein shut-off/RNA export were responsible for the attenuation of ONYX-015 in normal cells, we compared ONYX-053 and ORF6 complex is thought to be necessary for late viral RNA export, since late viral RNA export and protein expression have ONYX-015 replication in primary cells. Remarkably, despite the failure to degrade p53, ONYX-053 replication was only attenuated been reported to be defective in cells infected with E4-ORF6 adenoviral mutants (Cutt et al., 1987; Gonzalez and Flint, 2002;  2-to 3-fold compared to wild-type virus ( Figure 6C ). In contrast, ONYX-015 replication was attenuated 13-to 25-fold in the same Goodrum and Ornelles, 1999; Halbert et al., 1985) . The E1B-55K mutant expressed by ONYX-053 is severely compromised cells. The 2-to 3-fold reduction in ONYX-053 replication compared to wild-type virus may reflect a novel function of p53 in in its ability to bind to E4-ORF6 (Shen et al., 2001 ), consistent by providing the late functions of E1B-55K. To test this prediction, we examined late viral RNA export in HCT-116 cells infected with ONYX-015 and wild-type virus ( Figure 7A ). Even in the absence of E1B-55K, fiber RNA is exported efficiently to the cytoplasm in ONYX-015-infected HCT-116 cells analogous to a wild-type virus infection. Similar results were obtained in infected MDA-MB-361 breast tumor cells that are also permissive for ONYX-015 replication (Supplemental Figures S2A and  S2B) . We next examined host protein shutoff in HCT-116 cells infected with ONYX-015 or wild-type virus. Figure 7B demonstrates that there is a shutdown in cellular but not viral protein synthesis in ONYX-015-infected HCT-116 cells despite the absence of E1B-55K. Consistent with this, and in contrast to primary cells, there was no delay in the onset or level of late viral protein expression in ONYX-015-infected HCT-116 cells ( Figure  7C ). This is a general property of tumor cells that support ONYX-015 replication (Supplemental Figure S3) .
The mechanism by which tumor cells shut down the synthesis of cellular proteins is of considerable interest. Such a capability would be of no obvious benefit to tumor cell proliferation or survival. In adenovirus infection, expression of the late viral 100K protein inhibits the translation of capped cellular mRNAs, while viral RNAs are translated in a cap-independent manner due to their possession of a unique 5Ј UTR (Cuesta et al., 2000; Hayes et al., 1990) . Consistent with this, 100K mutant viruses are defective for host protein shutoff and replication (Hayes et al., Figure 5 . ONYX-053 uncouples the functions of E1B-55K in p53 degradation and host protein shutoff in infected primary cells 1990; Morin and Boulanger, 1986) . In Figure 7D we demonstrate that, in addition to fiber RNA, 100K RNA export is also defective Quiescent SAECs were infected with ⌬E1A, ONYX-015, ONYX-053, or WtD adenovirus at moi 10.
in ONYX-015-infected SAECS. Therefore, it will be interesting A: Lysates were generated at various h.p.i. and examined for p53 and E1B-to determine if the shutoff of host protein synthesis in permissive viral RNAs 5-10 times more efficiently than primary cells upon ONYX-015 infection, and selectively complement the loss of E1B-55K in viral replication. Consequently, and in contrast to primary cells, the percentage of late viral RNA in the cytoplasm of ONYX-015-infected tumor cells is approximately equivalent attenuating ONYX-015 replication in primary cells. Indeed, a to that of wild-type virus. Based on this evidence, we conclude similar reduction in ONYX-015 replication was observed in HCTthat the tumor-selective replication of ONYX-015 is determined 116 tumor cells when p14 ARF expression and p53 were restored by a novel and unprecedented difference between tumor and (Ries and Korn, 2002) . Alternatively, the small reduction in normal cells for the export of late viral RNAs, as depicted in ONYX-053 replication in normal cells may reflect the mild defect Figure 7D . in host protein shutoff in ONYX-053 versus wild-type virus infected cells ( Figure 5B ). Nevertheless, we conclude that the Discussion major mechanism underlying the failure of ONYX-015 to replicate in normal cells is the defective export of late viral RNAs ONYX-015 was originally conceived as a virus whose replication and/or defective host protein shutoff.
would be restricted to tumor cells that had inactivated p53. Consistent with this, ONYX-015 was shown to be safe and Permissive tumor cells provide the late viral RNA export undergo tumor-selective replication in Phase I and II clinical functions of E1B-55K trials (Khuri et al., 2000; Kirn, 2001; Reid et al., 2002;  Ries and These results indicate that ONYX-015 fails to replicate in normal Rudin et al., 2003) . However, patient responses did cells primarily due to the loss of E1B-55K functions unrelated not necessarily correlate with the p53 status of their tumors to p53 degradation. This implies that the tumor selectivity of (Khuri et al., 2000) , and indeed in cell culture, ONYX-015 was ONYX-015 is also likely to be determined by the same function shown to replicate in several tumor cell lines that retain wildof E1B-55K. Previous studies have indicated that cytoplasmic type p53 sequences (Goodrum and Ornelles, 1998 ; Harada and fiber and hexon RNAs correlate with tumor cell permissivity to Berk, 1999; Rothmann et al., 1998; Turnell et al., 1999) . One ONYX-015 Ornelles, 1998, 1999; Harada and interpretation of this data is that a p53-independent mechanism Berk, 1999). Thus, we predicted that tumor cells that support determined ONYX-015 selectivity in tumor cells. An alternative ONYX-015 replication to wild-type virus levels, such as HCTexplanation is that the p53 pathway is indirectly inactivated in these tumor cells through loss of p14 ARF , p53-responsive cell 116 cells (Harada and Berk, 1999; Ries and Korn, 2002) , do so Figure 6 . Loss of E1B-55K-mediated late viral RNA export, rather than p53 degradation, is the major limitation for ONYX-015 replication in primary cells A: Quiescent SAECs were infected with ONYX-015 or WtD at moi 10. Nuclear and cytoplasmic RNA were isolated at 24 and 36 h.p.i. and examined by real-time Q-PCR for the levels of spliced L5-fiber mRNA. The relative level of L5-fiber mRNA was determined as a % of 18S rRNA within the same samples. The cytoplasmic/nuclear ratio of fiber mRNA is plotted; standard error is represented. B and C: SAECs infected with ONYX-015, ONYX-053, or WtD at moi 10 were fixed at 48 h.p.i., and fluorescent in situ hybridization (FISH) was performed with either an anti-sense digoxigeninlabeled fiber (B) or hexon (C) RNA probe. Fiber and hexon RNAs were each detected using a FITC anti-digoxigenin-labeled secondary antibody. Cells were costained with mouse anti-E1B-55K, which was detected using an Alexa-532 anti-mouse antibody. Nuclei were counterstained with Hoescht and images acquired on a Zeiss Meta-Scanning Confocal Microscope. ⌬E1A infected cells showed only background staining for E1B-55K as well as fiber and hexon RNA. The specificity of the FISH probes for fiber and hexon RNAs, and not viral DNA, was confirmed by the failure to detect appreciable staining with either the digoxigenin-labeled fiber or hexon RNA probes to the coding strand in the same experiment. D: Virus production in quiescent SAECs infected with ONYX-015, ONYX-053, or WtD virus at moi 10 was determined at 52 and 72 h.p.i. A representative experiment that was measured in triplicate is shown.
cycle/apoptosis checkpoints, or novel components of the p53 largely irrelevant for ONYX-015 replication, a novel or unknown function of p53 in limiting viral replication could not be excluded. pathway (Ries et al., 2000) .
Due to the caveats of assessing p53 function in tumor cells For example, p53 has recently been shown to have transcriptionally independent effects in promoting apoptosis through in which the p53 pathway is generally defective, we chose instead to study ONYX-015 replication in primary epithelial cells localization to the mitochondria (Chipuk et al., 2004; Mihara et al., 2003) . Notwithstanding, our use of a novel adenovirus in which all components of the p53 pathway are intact. We demonstrate that, although nuclear p53 accumulates to high expressing an E1B-55K point mutant, ONYX-053, demonstrates that the major defect in ONYX-015 replication in primary cells levels in ONYX-015-infected primary cells, it is biologically inert. While these data strongly suggested that p53 is, therefore, is due to the loss of E1B-55K late functions unrelated to p53, although obviously it is impossible to exclude a function for p53 more, at least one late protein, 100K, plays multiple roles in virus production. 100K is necessary for the shutoff of host protein in vivo. Furthermore, we show that tumor cells that support ONYX-015 replication provide the function of E1B-55K in late synthesis and late viral RNA translation (Cuesta et al., 2000; Hayes et al., 1990; Huang and Schneider, 1991) and plays a viral RNA export. Based on this evidence, we conclude that the major determinant of ONYX-015 tumor selectivity is RNA export.
critical role in the morphogenesis and assembly of virion particles (Cepko and Sharp, 1982; Morin and Boulanger, 1986) . In The assembly of replication-competent viral particles depends upon the association of many late viral proteins and is addition, 100K is particularly required for hexon protein expression (Farley et al., 2004) , which is one of the late proteins that driven by a process of mass action. Therefore, changes in the concentration of multiple late viral proteins are expected to have is most affected by the loss of E1B-55K in ONYX-015-infected SAECS. We demonstrate that loss of E1B-55K also results in amplified effects on assembly. This is likely to account, in part, for how a 2-to 4-fold defect in the export and expression of a defect in 100K RNA export which could impact the production and assembly of infectious virions at multiple levels. Thus, we several late viral RNAs, such as hexon and fiber, could result in up to a 25-fold reduction in infectious viral particles. Furtherfavor the hypothesis that it is the cumulative defect in the export and expression of several late viral RNAs, rather than any single their cap-independent translation (Yueh and Schneider, 1996) as well as playing a role in their export (Huang and Flint, 1998) . RNA, that accounts for the defect in ONYX-015 replication in primary cells.
We are currently investigating whether cellular RNAs containing 5Ј UTRs that are structurally related to the late adenoviral 5Ј The loss of E1B-55K-mediated p53 degradation in ONYX-015-infected primary cells was expected to activate a p53 UTR are preferentially exported in tumor cells. Interestingly, increased replication of ONYX-015 in tumor cells has previously checkpoint that would limit viral replication. However, while both ONYX-015 and ONYX-053 induce high levels of nuclear p53 in been shown to correlate with S phase, as tumor cells vary in the extent to which they rescue ONYX-015 replication (Goodrum infected cells, this did not result in inhibitory biological effects on viral replication. One interpretation of these results is that and Ornelles, 1999). Therefore, the property of tumor cells to export late viral RNAs may be a result or function of deregulated inactivation of p53 may not be required for adenoviral replication after all. However, disparate DNA viruses have functionally conproliferation, as even proliferating normal cells do not support ONYX-015 replication (Table 1 and Johnson et al., 2002) . Possiverged to evolve proteins that inactivate p53; for example, HPV degrades p53 through the early viral protein E6, while SV40 ble insights into the mechanism of late viral RNA export in tumor cells may be derived from how E1B-55K functions in this Large T binds and inactivates p53 directly. Thus, a more plausible explanation is that adenovirus possesses yet another stratprocess. While differential RNA splicing has been suggested in tumor cells (Bartel et al., 2002) , alterations in RNA export remain egy that inactivates p53 in the absence of E1B-55K. The adenoviral proteins E1A and E1B-19K promote cell-cycle entry and unknown. Interestingly, NUP88 and NUP214, two nuclear pore prevent apoptosis (Debbas and White, 1993; White et al., 1991) , proteins implicated in RNA export, have been found as translorespectively; these functions could perhaps override the effects cation products in myeloid leukemia (Arai et al., 1997 ; Boer et of p53-induced downstream effectors on cell cycle entry or al. Nakamura et al., 1996) . However, the contributions apoptosis in ONYX-015-infected cells. However, the failure of of these mutations to tumorigenesis still remain to be elucidated, p53 to even induce the transcription of such downstream efas the regulation and mechanics underlying normal mammalian fectors in ONYX-015-infected cells suggests that p53 is inacti-RNA export are poorly understood. Nonetheless, the revelation vated more directly. One candidate for such a role is E4-ORF6, that late viral RNA export is the major determinant of ONYXthe binding partner of E1B-55K, which is also known to interact 015 tumor selectivity provides an important insight and impetus with p53 (Dobner et al., 1996) . An alternative candidate is E1A, for the study of RNA transport in tumorigenesis as well as for which binds and inactivates p300 (Chiou and White, 1997;  cancer therapy. Thomas and White, 1998) , an important coactivator for p53-Experimental procedures mediated transcription and histone acetylation (Espinosa and Emerson, 2001 ). Previous studies with ONYX-015 have used (Espinosa and Emerson, 2001) . Thus, it is intriguing to speculate that E1A itself may perhaps compromise p53 function in ONYX-
Virus infections and quantification
such as hexon and fiber, share a common 5Ј UTR that facilitates
